Kendall Law Group Launches Shareholder Investigation into Sale of Medarex
(DALLAS) Kendall Law Group (www.kendalllawgroup.com) is investigating the sale of Medarex (NASDAQ: MEDX) to Bristol-Myers Squibb. The law firm is investigating the sale because the tender offer price is well below the company’s peak historical share price and appears to be timed to take advantage of the global economic downturn.
For information about your rights as a Medarex shareholder, contact a Kendall Law Group attorney at 877-744-3728 or by email at administrator@kendalllawgroup.com . Kendall Law Group is led by a former federal judge and U.S. Attorney. The firm has nationwide experience representing investors in mergers and acquisitions.
Kendall Law Group, LLP
3232 McKinney, Ste. 700
Dallas, TX 75204
214-744-3000 Telephone
214-744-3015 Facsimile
877-744-3728 Toll Free
administrator@kendalllawgroup.com
www.kendalllawgroup.com